We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bendamustine

News List

NICE does not recommend polatuzumab vedotin to treat lymphoma europeanpharmaceuticalreview
March 03, 2020
NICE has formed a negative opinion for Polivy (polatuzumab vedotin) in combination with rituximab and bendamustine to treat diffuse large B-cell lymphoma.
ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL drugs
December 04, 2018
For older patients with untreated chronic lymphocytic leukemia (CLL), treatment with ibrutinib alone or in combination with rituximab is associated with improved.....
NHS England clears specialised treatments for NHS use pharmatimes
July 10, 2018
NHS England has approved routine funding for a stream of new specialised treatments, including stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy.